emerge weight loss semaglutide – GLP1 Match Pricing | Emerge Weight Loss

GLP-1 medications deliver substantially greater weight loss: semaglutide trials showed 1015% body weight reduction over 68 weeks, and tirzepatide (a dual GLP-1/GIP agonist) demonstrated 20%+ reductions in some cohorts

References Acosta, Andres, Alejandro Campos, Alan De la Rosa, Fauzi Feris, Wissam Ghusn, Lizeth Cifuentes, Maria Daniela Hurtado, and Daniel Sacoto Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity Hims & Hers Newsroom Hims & Hers is Delivering a New GLP-1

You may notice some or all the above in your kiddo when in this stage

The modeling process followed the protocol described in previous literature [19]

J.BrewB

Genome.gov